D
uring the development of hypertension, the L-type Ca 2+ (Ca v 1.2) channel encoded by the Ca v 1.2 gene is upregulated in vascular smooth muscle cells (VSMCs). [1] [2] [3] An overabundance of vascular Ca v 1.2 channels has been documented in rats with genetic, renal, and salt-dependent forms of hypertension. 4 At least 1 study suggests that even a short-term elevation of intravascular pressure increases expression of arterial Ca v 1.2 channels in vivo, implicating the upregulation of Ca v 1.2 channels as an early event in the pathogenesis of hypertension. 1 The increased expression of Ca v 1.2 channels enhances voltage-dependent Ca 2+ influx resulting in abnormal vasoconstriction, which can be reversed by pharmacological antagonists of the Ca v 1.2 channel.
1,2,5-7 Correspondingly, an increased Ca v 1.2 channel-mediated arterial tone in hypertensive animals and humans with essential hypertension may partly explain their sensitivity to the antihypertensive effect of clinical Ca 2+ channel antagonists that block Ca v 1.2 channels. The same drugs only mildly lower blood pressure in normotensive subjects. [8] [9] [10] [11] The mechanisms that mediate the upregulation of arterial Ca v 1.2 channels during hypertension are unclear, but appear to primarily rely on post transcriptional events because the increased expression of the Ca v 1.2 pore-forming α 1C subunit has not been linked to a corresponding increase of α 1C transcript. 2, 3 In the present study, we hypothesized that the regulatory β3 subunit (Ca v β3) of the Ca v 1.2 channel, which acts post transcriptionally to promote surface expression of the α 1C pore, may increase Ca v 1.2 channel abundance during hypertension. It is presumed that in VSMCs, similar to other cell types, the α 1C subunit coassembles with smaller β and α 2 δ subunits to form functional Ca 2+ channels. [12] [13] [14] [15] Four gene families (β1, β2, β3, and β4) encode Ca v β subunits in a tissue-specific manner. Ca v β3 is the principal subtype in VSMCs, 16, 17 where it is presumed to bind to α 1C in the endoplasmic reticulum (ER) to enhance its trafficking to the plasma membrane. At the cell surface, the multiprotein Ca v 1.2 channel assumes its critical function of mediating voltage-dependent Ca 2+ influx during membrane depolarization. −/− mice exhibited normal systolic blood pressure (SBP). 16, 17 This seeming dichotomy may indicate that blood pressure was sustained by compensatory mechanisms or that Ca 2+ influx through Ca v 1.2 channels contributes only minimally to basal blood pressure in normotensive subjects or both. [8] [9] [10] [11] Here, we considered the hypothesis that the regulatory Ca v β3 subunit promotes vascular Ca v 1.2 channel expression in hypertension, a disease in which this channel is pathogenically overexpressed. Our studies used Ca v β3 −/− mice to explore whether deletion of the Ca v β3 gene attenuates the upregulation of arterial Ca v 1.2 channels and the development of hypertension. The findings demonstrate that although Ca v β3 −/− mice show normal resting SBP, they fail to fully develop angiotensin II (Ang II)-dependent hypertension, and this loss of function is associated with an inability to upregulate arterial Ca v 1.2 channels. Thus, Ca v β3 may be a previously unrecognized but critical protein that contributes to the vascular Ca v 1.2 channel abnormalities that elevate blood pressure.
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Methods
Blood Pressure Measurement
Procedures using animals were approved by the institutional animal care and use committee at the University of Arkansas for Medical Sciences. SBP was recorded using tail-cuff plethysmography before and after implanting subcutaneous osmotic minipumps containing either saline (SAL) or Ang II (infused at 2 ng/g per minute).
Vessel Perfusion Assays
Second-order mesenteric arteries (MAs) were isolated from SALinfused and Ang II-infused hypertensive (AHT) mice, and used to perform vessel perfusion assays.
Patch-Clamp Studies
The VSMCs were enzymatically isolated from second-order MA branches, and whole-cell Ca 2+ channel currents were recorded using Ba 2+ (10 mmol/L) as a charge carrier with standard pulse protocols, solutions, and a patch-clamp station described previously. 
Quantitative Real-Time Polymerase Chain Reaction
Whole-tissue RNA was isolated from second-order branches of MA pooled from 2 mice. Then quantitative reverse transcriptase-polymerase chain reaction was performed using primers specific for α 1C , Ca v β3, and GAPDH.
Western Blotting
Protein lysates were prepared by pooling MAs from 2 mice.
1 Specific polyclonal antibodies directed against epitopes specific to α 1C and Ca v β3 were used as probes.
Statistics
Data represent mean±SEM for the number of animals indicated in parentheses. Student t test was used to compare 2 data sets, and 1-way ANOVA with Bonferroni post hoc test was used for multiple group comparisons. P≤0.05 was considered significant.
Results
Ca v 1.2 Channel α 1C and β3 Subunits Upregulate in MAs of AHT Mice
Initially, we determined whether vascular Ca v 1.2 channels upregulate in Ang II-infused C57BL/6 mice, because previous studies demonstrating Ca v 1.2 channel upregulation were performed only in hypertensive rat models. Figure S1 in the online-only Data Supplement shows that 14 days of subcutaneous Ang II infusion (2 ng/g per min) resulted in SBP values of 106 ± 2, 155 ± 5, and 172 ± 8 mm Hg at 0, 7, and 14 days, respectively (n=10 each). The SBP values in SAL mice did not significantly differ from a basal value of 104 ± 3 mm Hg. Subsequent studies were performed using mice infused with SAL or Ang II for 2 weeks.
Next, we determined whether the MA of AHT mice showed an increased expression of the α 1C and Ca v β3 subunits that coassemble to form functional Ca v 1.2 channels. Adjacent lanes on Western blot were loaded with MA lysate from SAL or AHT mice. The α 1C protein was upregulated 2.4 ± 0.4-fold in the MA of AHT mice compared with SAL mice ( Figure 1A and 1B). The abundance of the Ca v β3 subunit also increased during the development of hypertension. The immunodensity of the Ca v β3 band was 2.8 ± 0.6-fold higher in MA lysate from AHT mice compared with SAL mice ( Figure 1A and 1C) . Interestingly, quantitative reverse transcriptase-polymerase chain reaction experiments using total RNA isolated from MA of SAL and AHT mice revealed that the transcript levels of both α 1C (C T values SAL 24.2 ± 0.3, AHT 24.1 ± 0.3) and Ca v β3 (C T values SAL 25.1 ± 0.5, AHT 25.1 ± 0.6) were similar between the 2 isolates ( Figure 1D ). The C T values were normalized to GAPDH, which was used as an amplification standard.
Increased Ca v 1.2 Channel Current and Vascular Reactivity in AHT Mice
We confirmed that the overabundance of Ca v 1.2 channels in MA of AHT mice was associated with enhanced channel function. Patch-clamp studies revealed increased Ca v 1.2 channel-mediated current in mesenteric VSMCs of AHT compared with SAL animals ( Figure 2A , top traces), which were blocked by nifedipine ( Figure S2 ). Current-voltage relationships suggested a 1.9 ± 0.2-fold increase in peak current density in the VSMCs of AHT mice (−10.7 ± 1.0 pA/pF) compared with SAL mice (−5.6 ± 0.7 pA/pF; Figure 2A Figure 3A and 3B, n=12 each). Resting SBP levels also were similar between WT mice (98 ± 2 mm Hg) and Ca v β3 −/− mice (102 ± 3 mm Hg; Figure  S4A , n=10). The resting heart rate of 555 ± 8 beats/min in WT mice (n=10) and 563 ± 10 beats/min in Ca v β3 −/− mice (n=11) also was not different ( Figure S4B ).
Ca v β3 −/− Mice Fail to Fully Develop Hypertension
Subsequently, we explored whether the Ca v β3 subunit contributes to the development of Ang II-dependent hypertension, which we postulated may partly rely on upregulation of Ca v 1.2 channels. WT and Ca v β3 −/− mice were infused with SAL or Ang II for 2 weeks, and SBP was recorded for 3 days before infusion (day 0) and on days 4, 7, 10, and 14 after infusion. As expected, WT and Ca v β3 −/− mice infers that factors in addition to the upregulation of Ca v 1.2 channels contribute to the elevated blood pressure in this form of hypertension, reflecting its complex pathogenesis as reviewed by Hall. 18 Many studies during the past decade have shown that hypertension is associated with an elevated Ca 2+ influx through arterial Ca v 1.2 channels.
14 At least 3 rat models of hypertension show an increased density of functional Ca v 1.2 channels in the VSMCs of the aorta and in vascular beds involved in blood pressure regulation. [1] [2] [3] 5, 6 In the renal circulation of aortic-banded rats, an increased Ca v 1.2 channel expression occurs by 48 hours after blood pressure elevation. 1 Thus, an upregulation of Ca v 1.2 channels, the opening of which may be driven by the depolarized membrane potential of VSMCs exposed to high intravascular pressure, appears to contribute to the elevated vascular tone of hypertension.
1,2 An increased Ca 2+ -dependent reactivity, and an enhanced vasodilator sensitivity to nifedipine, also has been reported in MA segments from hypertensive patients. 7 These findings, combined with the observation that the blood pressure-lowering effect of calcium channel blockers is exaggerated in hypertensive patients, 8, 9 raise the possibility that Ca v 1.2 channel abnormalities extend to essential hypertension in humans.
Here, we extend earlier findings in rats to the AHT mouse by confirming that MAs from AHT mice show increased Ca v 1.2 channel expression and Ca 2+ -dependent reactivity compared with arteries from SAL mice with normal blood pressure. Similar to earlier studies in rats, [1] [2] [3] we failed to detect a major increase of α 1C transcript in arteries of AHT mice that could account for the marked overabundance of the α 1C protein. Thus, the upregulation of arterial Ca v 1.2 channels in AHT mice appears to rely on post transcriptional mechanisms that could include increases in translational efficiency or channel biogenesis or both, trafficking, or surface stability.
In this regard, Ca v β subunits are known to increase the surface density of Ca 2+ channels, although most studies have been performed in heterologous expression systems 19, 20 or nonvascular cell types. 21, 22 The Ca v β subunits coassemble with poreforming α-subunits during channel biogenesis to promote the trafficking of the Ca 2+ channel complex from the ER to the plasma membrane. 14, 19 Although Ca v βs are postulated to mask an ER retention signal in α-subunits as a mechanism to target Ca 2+ channels to the cell surface, no specific motif has been identified. Altier −/− mice was associated with a blunted blood pressure response to Ang II. Thus, our findings suggest an association between the Ca v β3 subunit, Ca v 1.2 channel upregulation, and hypertension. Notably, the deletion of Ca v β3 was not limited to VSMCs in the Ca v β3 −/− mice of our study, and thus we cannot state with certainty that the failure of Ca v β3 −/− mice to fully develop Ang II-dependent hypertension relied on Ca v β3 deletion in VSMCs rather than nonvascular cell types. Although the Ca v β3 −/− mouse has no gross phenotype, the Ca v β3 subunit also is extensively expressed in the brain and may negatively regulate N-methyl D-aspartate receptors and potentially affect other neuronal functions. 26 For this reason, the design of new Ca v β3 −/− mice showing conditional and SMC-specific Ca v β3 gene deletion will be required to directly test the hypothesis that arterial Ca v β3 subunits contribute to experimental hypertension.
Notably, Fan et al 22 designed mutant Ca v β subunits that interact with α 1C intracellularly, but lack the motifs required to target the Ca v 1.2 channel complex to the plasma membrane. These β subunit decoys represent potential therapeutics to reduce Ca v 1.2 channel surface expression in cardiovascular pathologies characterized by an overabundance of Ca v 1.2 channels. 22, 27, 28 It may be advantageous to ameliorate anomalous Ca 2+ influx by preventing the upregulation of Ca v 1.2 channels rather than using pharmacological blockers to reduce the activity of overexpressed channels. Our findings provide proof-of-principle for this concept by showing that Ca v β3 deletion can normalize Ca v 1.2 channel expression in VSMCs of hypertensive mice in which Ca v 1.2 channel overexpression is a contributing defect.
Perspectives
To our knowledge, the present study provides the first evidence to implicate a distinct Ca 2+ channel β subunit in the development of hypertension. It has been proposed that small molecule inhibitors of Ca v β subunits represent future therapies to lower Ca 2+ channel abundance in conditions associated with excessive Ca 2+ influx including hypertension. Our findings support the concept that strategies to knockdown or inhibit the Ca v β3 subunit in VSMCs and thereby reduce Ca v 1.2 channel expression in the arterial circulation may represent novel therapeutic approaches for lowering blood pressure in hypertensive subjects.
What Is New?
• A β3 protein increases the number of voltage-gated Ca 2+ channels in arteries during hypertension.
• Mice in which the β3 protein is deleted fail to fully develop hypertension.
What Is Relevant?
• The abnormal contraction of small arteries during hypertension is partly caused by the presence of too many Ca 2+ channels.
• Here, we report that a β3 protein is required for Ca 2+ channels to increase in arteries during hypertension and lack of this protein reduces the level of blood pressure elevation.
Summary
The β3 subunit is a critical protein in arteries that contributes to the upregulation of voltage-gated Ca 2+ channels and the development of hypertension. 
Novelty and Significance
Blood pressure measurement and minipump implantation
Systolic blood pressure (SBP) was recorded using tail-cuff plethysmography (IITC Life Science, Woodland Hills, CA). Briefly, 10 to 12 week-old mice were trained for one week (once daily) before recording baseline SBP for 3 consecutive days. For implanting osmotic minipumps, mice were anesthetized with 5% isoflurane and maintained with 2% isoflurane inhalation in 100% O 2 . Osmotic minipumps (Alzet 2004, Durect Corporation, Cupertino, CA) containing angiotensin II (Ang II, Bachem, Torrance, CA, infusion rate: 2 ng/g/min), or an equal volume of vehicle (0.9% saline) were implanted subcutaneously. After recovery from anesthesia, mice were housed in individual cages and allowed free access to food and water. The SBP recordings were continued on days 4, 7, 10 and 14 following minipump implantation.
Vascular reactivity assays
Second order mesenteric arteries (MA) were isolated from saline and Ang II-infused mice. After cleaning of adhered fat and connective tissue, arteries were placed in physiological salt solution (PSS) containing (in mmol/L): NaCl (119), KCl (4.7), MgSO 4 (1.17), NaHCO 3 (24) , EDTA (0.026), NaH 2 PO 4 (1.17), glucose (5.55) and CaCl 2 (1.6) in a heated (37°C) chamber bubbled with a 95% O 2 -5% CO 2 gas mixture. MA were cannulated on both ends with tapered glass micropipettes in a microvessel perfusion system (Living Systems, St. Albans, VT). 2 Arteries were perfused with PSS at an intraluminal pressure of 80 mm Hg with no outflow. The PSS in the chamber was exchanged every 15 minutes during equilibration and after application of reagents. After equilibration for 1 hr, the viability of MA was verified by observing a contractile response to 60 mmol/L KCl. Internal diameter changes were recorded using an upright microscope/Spot RT camera operated with MetaVue acquisition software (Molecular Devices, Inc. Sunnyvale, CA) and analyzed with an automated edge-detection script in IPlab software (BD Biosciences, San Jose, CA).
Patch clamp studies
VSMCs were enzymatically isolated from 2 nd order MA branches and whole-cell Ca 2+ channel currents were recorded using standard pulse protocols, recording solutions and a patchclamp station described previously. 2, 3 Briefly, recordings were obtained at 25°C using 10 mmol/L BaCl 2 as a charge carrier to limit current rundown. With the use of -70 mV as the constant inter-pulse holding potential, whole-cell currents were elicited in response to progressive 8 mV voltage steps from -70 mV to +58 mV. The identity of Ca v 1. V 1/2 )/s), where V is the command voltage, V 1/2 is the half-maximal potential, s is the slope factor, A 1 is the maximum value of the ratio I/Imax (fixed at 1), and A 2 is the minimum value of the ratio I/Imax. Data analysis was performed using Clampfit (Molecular Devices, Inc. Sunnyvale, CA) and Origin (OriginLab Corp., Northampton, MA).
Quantitative real-time PCR
Total RNA was isolated using RNeasy Plus Mini kit (Qiagen Inc., Valencia, CA) from 2 nd order branches of MA pooled from two mice. RNA concentration and purity was measured using a Nanodrop spectrophotometer (ND1000, Thermoscientific, Wilmington, DE). The cDNA was synthesized from DNase-treated RNA samples using High Capacity RNA-to-cDNA Kit (Applied Biosystems, Carlsbad, CA). After reverse transcription, quantitative real-time PCR was performed using an iCycler iQ ® System (Bio-Rad, Hercules, CA) and primers specific for α 1C (F = 5'-TGTCCCTCTTCAACCGCTTTGACT-3' R = 5'-GTTCAGCAAGGATGCCACAAGGTT-3', β3 (F = 5'-TGAGGTCACGGACATGATGCAGAA-3' R= 5'-TGATGGTCCTCTTGCCAG GATTGT-3'), or GAPDH (F = 5'-TGGCAAAGTGGAGATTGTTG-3', R = 5'-CATTATCGG CCTTGACTGTG-3') sequences. In some experiments, PCR was paused on the steep slope of the amplification curve and amplified products were loaded on a 2% agarose gel to verify a single band of expected size and visualize their abundance using the Molecular Imager Gel Doc system (Bio-Rad, Hercules, CA).
Western blotting
Lysates were prepared by pooling MA from two mice in tissue lysis buffer containing (in mM): HEPES (50), NaCl (150) EGTA (1) MgCl 2 (1.5), PMSF (0.01), 1% Triton X-100, 10% glycerol and 5 μg/mL of the following protease inhibitors: leupeptin, aprotinin,and antipain. The protein concentration was measured using the Bradford protein assay. Forty micrograms of the total protein was subjected to gel electrophoresis under reducing conditions on 7% tris acetate gels and electrophoretically transferred to a PVDF membrane using a XCell SureLock™ MiniCell Western blotting kit (Invitrogen, Carlsbad, CA). The membranes were then blocked with 10% non-fat dry milk (Bio-Rad, Hercules, CA) prepared in tris-buffered saline containing 0.5% Tween-20 (TBST) and incubated overnight at 4°C with primary antibodies reconstituted in 5% milk. Specific polyclonal antibodies raised against α 1C (1:200, Alomone) and Ca v β3 (1:2500, Abcam), or monoclonal anti-GAPDH (Sigma-Aldrich, St. Louis, MO) were used for protein detection. After incubation with primary antibodies, the membranes were incubated for one hour at room temperature in HRP linked secondary anti-rabbit (1:5000) or anti-mouse (1:20,000) antibodies (GE healthcare, Piscataway, NJ). Membranes were washed with TBST (3 times, 10 minutes per rinse), and bands were identified by chemiluminescence on X-ray film. Figure S1 . The SBP profiles of C57BL/6 mice infused with isotonic saline (vehicle, SAL) or Ang II (2 ng/g/min, AHT) respectively, for two weeks. Values of SBP at weeks 1 and 2 in SAL mice were not significantly different from baseline at week 0 (n=10). However, SBP was significantly increased at weeks 1 and 2 after the start of Ang II infusion in AHT mice (n=10). * = p<0.05. -/-mice (n=10 each). B. Resting heart rate also was not significantly different between WT and Ca v β -/-mice (n=10, 11).
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